MedPath

ELAN PHARMACEUTICALS

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:4

Trial Phases

4 Phases

Phase 1:2
Phase 2:1
Phase 3:3
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 3
3 (42.9%)
Phase 1
2 (28.6%)
Phase 2
1 (14.3%)
Phase 4
1 (14.3%)

A Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Phase 1
Terminated
Conditions
Multiple Sclerosis
Interventions
First Posted Date
2011-03-18
Last Posted Date
2015-12-14
Lead Sponsor
Elan Pharmaceuticals
Target Recruit Count
12
Registration Number
NCT01318421

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Phase 1
Terminated
Conditions
Multiple Sclerosis
Interventions
Drug: Placebo
First Posted Date
2010-06-15
Last Posted Date
2015-12-14
Lead Sponsor
Elan Pharmaceuticals
Target Recruit Count
32
Registration Number
NCT01144351
Locations
🇨🇦

Research Site, Montreal, Quebec, Canada

Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain

Phase 3
Completed
Conditions
Pain
First Posted Date
2004-02-04
Last Posted Date
2015-12-14
Lead Sponsor
Elan Pharmaceuticals
Target Recruit Count
300
Registration Number
NCT00076544
Locations
🇺🇸

Alabama Pain Center, Huntsville, Alabama, United States

🇺🇸

Center for Pain Management, Huntsville, Alabama, United States

🇺🇸

Otto Uhrik, MD, Sun City West, Arizona, United States

and more 60 locations

A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache

Phase 2
Completed
Conditions
Migraine Headache
First Posted Date
2003-03-05
Last Posted Date
2015-12-14
Lead Sponsor
Elan Pharmaceuticals
Target Recruit Count
204
Registration Number
NCT00055484
Locations
🇺🇸

Medical Affiliated Research Center, Huntsville, Alabama, United States

🇺🇸

University of South Alabama Medical Ctr Department of Neurology, Mobile, Alabama, United States

🇺🇸

Valley Neurological Headache Clinic, Phoenix, Arizona, United States

and more 9 locations

Prialt (Ziconotide) In Severe Chronic Pain

Phase 3
Completed
Conditions
Pain
First Posted Date
2002-10-17
Last Posted Date
2015-12-14
Lead Sponsor
Elan Pharmaceuticals
Target Recruit Count
220
Registration Number
NCT00047749
Locations
🇺🇸

Tennesee Valley Pain Consultants - Center For Pain Management, Huntsville, Alabama, United States

🇺🇸

The Pain Center, Northport, Alabama, United States

🇺🇸

Outcomes Research International, Tucson, Arizona, United States

and more 41 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.